Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Teva Pharmaceutical Industries Ltd (TEVA)

17.27 -0.29 (-1.65%)

04-25 16:00

Open:

17.53

Pre. Close:

17.56

High:

17.58

Low:

16.965

Volume:

8,111,882

Market Cap:

17562M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

17.578 - 17.696

17.696 - 17.794

Low:

16.746 - 16.86

16.86 - 16.954

Close:

17.062 - 17.248

17.248 - 17.403

Technical analysis  (as of: 2018-04-25 4:31:28 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 20.59     One year: 21.51

Support:

Support1: 16.35    Support2: 13.60

Resistance:

Resistance1: 17.63    Resistance2: 18.42

Pivot:

17.69

Moving Averages:

MA(5): 17.63     MA(20): 17.52

MA(100): 18.65     MA(250): 21.01

MACD:

MACD(12,26): -0.13     Signal(12,26,9): -0.17

%K %D:

%K(14,3): 52.10     %D(3): 62.01

RSI:

RSI(14): 40.51

52-Week:

High: 33.82  Low: 10.85  Change(%): -45.7

Average Vol(K):

3-Month: 1265487  10-Days 745906

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TEVA has closed above bottom band by 19.9%. Bollinger Bands are 52.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to TEVA's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-25T18:51:00-04:00
Cramer's lightning round: Teva Pharmaceuticals is 'not good enough' for your portfolio

2018-04-24T14:28:02-04:00
By The Numbers: Healthcare Stocks With Big Cash Distributions

2018-04-24T01:42:47-04:00
JF's Core Biotech Buys #12: Updates And Introducing Our 18th Selection

2018-04-23T08:30:00-04:00
Teva to Report First Quarter 2018 Financial Results on May 3, 2018

2018-04-21T09:30:08-04:00
Stocks To Watch: Earnings Blockbusters And Trump Talks Drug Prices

2018-04-21T08:38:00-04:00
The Passive DGI Core Portfolio: Income, Safety, And Growth

2018-04-20T08:10:30-04:00
Teva Continues To Deliver But Analysts Stay Bearish

2018-04-19T13:18:28-04:00
Novartis Q1 results weigh on pharma stocks

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

1016.88

Shares Float (M)

1014.47

% Held by Insiders

0.20

% Held by Institutions

61.60

Shares Short (K)

59397

Shares Short Prior Month (K)

67930

Stock Financials

EPS

3.880

EPS Est. Current Year

4.230

EPS Est. Next Year

3.690

EPS Est. Next Quarter

1.090

Forward EPS

2.780

Book Value (p.s.)

1.310

PEG Ratio

-1.28

Profit Margin

Operating Margin

17.77

Return on Assets (ttm)

-20.2

Return on Equity (ttm)

-76.1

Qtrly Rev. Growth

-15.9

Gross Profit (p.s.)

10.645

Sales Per Share

EBITDA (p.s.)

-15.137

Qtrly Earnings Growth

Operating Cash Flow (M)

3510.00

Levered Free Cash Flow (M)

3530.00

atoplab.com

Valuation

P/E

4.44

P/E Growth Ratio

-0.02

P/BV

13.15

P/S

797757568.00

P/CF

4.99

Dividend Yield

0.11

Dividends & Splits

Dividend

1.908

Dividend Pay Date

2017-12-12

Ex-Dividend Date

2017-11-27

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.